Presenter: Ralph Carson, LD, RD, PhD
CME: 1.0 AMA PRA Category 1 Credit™
Format: 1 hour video lecture
The use of humor and laughter in psychotherapy has great potential in a treatment setting, especially for eating disorders. Laughter provides levity in broaching sensitive topics, stimulating insights, diffusing anger, and relating to patients in a more intimate way. The intention of this course is to communicate the value of bringing humor into the therapy session, to provide an assortment of skills and tools to implement humor; and to promote humor as a technique for achieving recovery in the eating disorder population.
In this course, Dr. Carson will discuss the genetics and neuroscientific foundations of laughter, the therapeutic benefits of laughter, and how it restructures neurological pathways, especially for patients with depression. You’ll discover how to work with patients on developing a sense of humor, and bring laughter into therapy sessions with a “humor kit” to generate humor as an alternative to dysfunctional eating behaviors.
After completing this program, participants will be able to:
- Describe the physiology and science of smiling, humor and laughter
- Identify approaches to utilize laughter and humor therapeutically
Please click to expand each section and view accreditation information.
DURATION OF ACTIVITY
June 20, 2022 through June 19, 2024
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of MedicusCME and Comprehensive Psychiatric Resources, Inc. MedicusCME is accredited by the ACCME to provide continuing medical education for physicians.
MedicusCME designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Smiling, humor and laughter all have a physiological role in human health. Utilizing humor and laughter in therapy, when used appropriately, can have multiple benefits for patients.
HOW TO CLAIM CREDIT
In order to receive AMA PRA Category 1 credit™, participants must do the following:
Read the learning objectives and faculty disclosures
Participate in the activity, review course content and learning strategies, resources and support materials provided
Complete the post-test and activity evaluation
- Achieve a score of 80% or higher on the post-test
PLANNER CONTENT EXPERT
James Greenblatt, MD
Chief Medical Officer and Vice President of Medical Services
Walden Behavioral Care, Waltham, Massachusetts
Assistant Clinical Professor of Psychiatry
Tufts University School of Medicine
FACULTY CONTENT EXPERT
Ralph Carson, CED-RD, RD, PhD
Senior Clinical and Research Advisor, Eating Recovery Center-Pathlight Mood and Anxiety
Clinical Nutritional Advisor, Pine Grove Behavioral Health and Addiction Services
DISCLOSURE OF FINANCIAL RELATIONSHIPS
MedicusCME requires instructors, planners, managers, and others in control of educational content to disclose all their financial relationships with ineligible companies over the previous 24 months. All identified financial relationships are thoroughly vetted and mitigated according to MedicusCME policy.
James Greenblatt, MD has disclosed a financial relationship with Pure Encapsulations and Jaymac Pharmaceuticals for his role as consultant.
All other planners and faculty, including MedicusCME planners and managers, have no relevant financial relationships with ineligible companies to disclose. Any relevant financial relationships listed for planners or content contributors have been mitigated according to MedicusCME policies.
This activity is not supported by funds from an ACCME-defined ineligible company.
HIPPA COMPLIANCE ATTESTATION
In accordance with the Health Insurance Portability and Accountability Act (HIPAA), this educational activity, especially when utilizing patient cases for learning demonstration, will not include individually identifiable health information.
DISCLOSURE OF UNLABELED USE
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the Food and Drug Administration (FDA). The planners of this activity do not recommend the use of any agent outside of the labeled indications. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Let’s redefine mental wellness together.
Sign-up now for the latest in functional news and research, course launches, exclusive offers and more.
By submitting your information, you agree to receive future email communications from us. We promise to keep your information private, and you can easily unsubscribe at any time.